Sarepta Therapeutics Inc
Sarepta Therapeutics Faces 40% Stock Drop: What This Means for the Future of Gene Therapy
Shares of Sarepta Therapeutics tumbled over 30% recently, raising concerns about the future of its gene therapy treatment, Elevidys. The ... Read more
Market Update: Key Indices Rise on Trump’s Denial of Powell’s Firing – What It Means for Futures Today
Traders at the New York Stock Exchange on July 15, 2025, were in for a rollercoaster ride. After a positive ... Read more
